Genetics

Ancient epigenetic changes silence cancer-linked genes

An epigenetic change, a form of DNA control, that deactivates some genes linked to cancer late in human development has been conserved for more than 400 million years, new research led by the Garvan Institute of Medical Research ...

Obstetrics & gynaecology

Do women regret embryo testing before IVF?

The most effective way to increase the odds that an embryo will successfully implant during in vitro fertilization (IVF) is genetic testing to see if the embryo is normal.

Genetics

What can be done to prevent another CRISPR crisis?

The public announcement last fall from China regarding gene editing on human embryos, conducted without the benefit of scientific review or ethical debate, was met with worldwide disdain. It also has raised global concerns ...

Obstetrics & gynaecology

Artificial intelligence approach optimizes embryo selection for IVF

A new artificial intelligence approach by Weill Cornell Medicine investigators can identify with a great degree of accuracy whether a 5-day-old, in vitro fertilized human embryo has a high potential to progress to a successful ...

Genetics

Are mosaic embryos the 'dark horse' of IVF?

Not every embryo contains 46 perfect chromosomes. Some have more, others have fewer. The result is a common abnormality known as aneuploidy, which occurs in as many as 80 percent of human embryos.

Medical research

Japan okays research using human cells in animals

Japan has given the green light to a controversial research process involving implanting animals with human stem cells that could eventually help grow human organs for transplant inside animal hosts.

Genetics

'CRISPR babies': What does this mean for science and Canada?

In the wake of the announcement in China last November of the first 'CRISPR babies', Prof. Bartha Knoppers and researcher Erika Kleiderman from McGill's Centre of Genomics and Policy (CGP) have published a commentary article ...

Genetics

Perspectives on gene editing

Medicine is at a turning point, on the cusp of major change as disruptive technologies such as gene, RNA, and cell therapies enable scientists to approach diseases in new ways. The swiftness of this change is being driven ...

page 7 from 19